Wrld on Drugs
2018 mixtape by Future and Juice Wrld
Wrld on Drugs, also known and stylized as Future & Juice WRLD Present... WRLD ON DRUGS is a collaborative commercial mixtape by American rappers Future and Juice Wrld. It was released as a surprise on October 19, 2018, by Epic Records, Freebandz, Grade A and Interscope Records after being originally announced two days prior. The lead single "Fine China" was released on October 15, 2018. The mixtape contains guest appearances from Young Scooter, Young Thug, Lil Wayne, Yung Bans, Gunna, and Nicki Minaj.
Background
After the release of "Fine China", Wrld on Drugs was revealed as a joint project by both Future and Juice Wrld on their social media accounts. The project consists of sixteen songs. A handwritten track list featuring scribbling on a whiteboard was published by both the artists with the caption "Pluto x Juice #WRLDONDRUGS", which refers to Future as Pluto, a reference to Future's debut album Pluto. Future also revealed he and Juice Wrld have worked in the studio on the project, urging the latter to "make the cover artwork, pick the songs and put it out ASAP." He stated "Me & JuiceWorlddd in the studio rite now...we jus did enough heat to drop a tape this week." On the whiteboard, the phrases "whatever you addicted too" and "$$$ is a drug?" were written.
The Source has linked the album's title to the passing of rapper Mac Miller, stating "The title itself is interesting and speaks to the current state of Hip-Hop.
“Wrld on Drugs” enters the record as 2018 mixtape by Future and Juice Wrld. Crown Archives preserves that source wording while asking what Wrld, Drugs and mixtape can confirm, complicate or overturn.
Why this record matters
“Wrld on Drugs” is worth following because a concise public description often conceals a longer documentary argument. Here, Wrld, Drugs and mixtape provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jul 28, 2026. The linked authority identifier is Q58331141. 1 of 1 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 2018.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Wrld on Drugs”, its source revision and the description used here.
- Expand the search: follow Wrld on Drugs primary sources, Wrld on Drugs archive and Wrld research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Wrld on Drugs”?
- What terminology or title could unlock a more precise catalogue search?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Wrld on Drugs” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.